Hebrew version לגרסה בעברית
More than three years have passed since the beginning of Israel’s Covid-19 vaccine campaign. Pfizer CEO has called Israel ‘The world’s lab’ due to its commitment to use Pfizer’s BNT162b2 vaccine exclusively and the fast, colossal response to its vaccine campaign (8M doses within two months, in a total pop. of 10M people, according to IMOH dashboard).
Several researches have been published based on the data from Israel’s health system, and Israel was the one to raise the flag regarding vaccine-induced myocarditis and pericarditis (Hebrew. N12 news, April 23 2021, 45:37).
Nevertheless, much of the data collected has not been published, and some of it is de-facto inaccessible to researchers, healthcare workers and to the public.
Who we are and what we do
We are a group of doctors and researchers who are actively following up on the vaccine campaign in Israel and monitoring the healthcare system for possible safety signals. Our findings are based strictly upon official sources of information:
Freedom Of Information Act (FOIA) requests to the Israeli Ministry Of Health, HMO’s (Kuppot Holim), and hospitals
Weekly epidemiological reports published on IMOH’s web site
Additional reliable sources which could be verified and published
We declare that we have no conflict of interests
We are not looking for financial support
What we found
Our analysis shows several safety signals. We do not claim that there is a causal relationship to the Covid-19 vaccine, but in our opinion these signals are strong enough to conduct further investigation.
Limitations
We rarely have access to the full data necessary to conduct a deeper research.
Our work is purely on a voluntary basis. Therefore our scientific work is in some cases limited.
We make no claims. We publish official facts and data, and we trust the reader to review those with critical thought. Consider this as if a colleague approaches you at lunch, saying ‘Can you take a look at this?’
What we ask of you
Please subscribe and share IsraeLab substack with your colleagues.
